Application of the American Society of Clinical Oncology frameworks to compare tyrosine kinase inhibitors used in first line treatment of metastatic renal cell carcinoma: Had we solved the mystery?
about
Application of the American Society of Clinical Oncology frameworks to compare tyrosine kinase inhibitors used in first line treatment of metastatic renal cell carcinoma: Had we solved the mystery?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Application of the American So ...... ma: Had we solved the mystery?
@en
type
label
Application of the American So ...... ma: Had we solved the mystery?
@en
prefLabel
Application of the American So ...... ma: Had we solved the mystery?
@en
P2860
P1476
Application of the American so ...... ma: had we solved the mystery?
@en
P2093
Noha Elbaghdady
P2860
P304
P356
10.1080/14737140.2017.1372197
P577
2017-09-07T00:00:00Z